Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
2024年6月7日 - 7:30PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a)
of the Securities Exchange Act of 1934
| | | | | |
Filed by the Registrant x | Filed by a Party other than the Registrant ☐ |
| | | | | |
Check the appropriate box: |
☐ | Preliminary Proxy Statement |
☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
☐ | Definitive Proxy Statement |
x | Definitive Additional Materials |
☐ | Soliciting Material under §240.14a-12 |
HAEMONETICS CORPORATION
(Name of Registrant as Specified in Its Charter)
| | | | | |
| Payment of Filing Fee (Check the appropriate box): |
| x | No fee required. |
| ☐ | Fee paid previously with preliminary materials. |
| ☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |
Haemonetics (NYSE:HAE)
過去 株価チャート
から 5 2024 まで 6 2024
Haemonetics (NYSE:HAE)
過去 株価チャート
から 6 2023 まで 6 2024
